Oxford-AstraZeneca Covid vaccine shows an average 70% effectiveness in preventing the virus

November 23rd, 2020|

British pharmaceutical giant AstraZeneca said Monday an interim analysis of clinical trials showed its coronavirus vaccine has an average efficacy of 70% in protecting against the virus. It comes after a string of encouraging vaccine results in recent weeks, following late-stage trial readouts from Pfizer-BioNTech and Moderna. Pfizer and Moderna reported preliminary results showing that their respective Covid vaccines were around

October existing home sales see ‘spectacular’ 26.6% annual gain even with short supply and surging prices

November 19th, 2020|

Sales of existing homes in October soared well past expectations, rising 4.3% compared with September and 26.6% annually to a seasonally adjusted annualized rate of 6.85 million units, according to the National Association of Realtors. The NAR’s chief economist, Lawrence Yun, called the annual increase “a spectacular gain.” The annualized sales rate is the highest

Why Moderna’s Vaccine Win Is a Giant Leap Against Pandemics

November 16th, 2020|

By Max Nisen (Bloomberg Opinion) -- The world now seems likely to have at least two effective vaccines against Covid-19 with Monday's announcement of positive early data from Moderna Inc.’s 30,000-person clinical trial. The result comes a week after Pfizer Inc. and BioNTech SE revealed a protection rate of more than 90% protection against disease. Moderna slightly one-upped

We can stop COVID-19: Moderna vaccine success gives world more hope

November 16th, 2020|

(Reuters) - Moderna Inc’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations. Together with Pfizer Inc’s vaccine, which is also more than 90% effective, and pending more safety data and

‘Enterprise software is recession proof,’ according to a new report that tracked how the pandemic affected 400 firms

November 12th, 2020|

By Rosalie ChanNovember 12, 2020 Cloud-based enterprise software companies seem recession-proof, according to a new report from OpenView Venture Partners with data from over 1,200 enterprise cloud software firms between 2018 and 2020, with 400 respondents this year. These companies responded quickly to the coronavirus pandemic and their software became a necessity for many customers,

‘We’re not going back to the same economy’: The rise of technology poses risks to low-paid service workers amid the ongoing recovery, Fed Chair Powell says

November 12th, 2020|

By Ben WinckNovember 12, 2020 The US economy won't return to the exact same state it was in before the pandemic, Federal Reserve Chair Jerome Powell said Thursday. The health crisis is accelerating digitization throughout the economy, and Americans already slammed by the virus's fallout are at the highest risk of losing their jobs, he